Home › Pericardial Disorders › Vermont
Pericardial Disorders clinical trials in Vermont
3 studies for Pericardial Disorders are looking for participants at sites in Vermont.
Cities in Vermont
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
- Investigational Site 042, Burlington
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Oct 28, 2026 · NCT07010159An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
- Local Site #840022, Burlington
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 9, 2026 · NCT06836232CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
- University of Vermont, Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06708299From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.